-
Authors :
Dougé A; CHU de Clermont-Ferrand, service d'hématologie clinique adulte et de thérapie cellulaire, 63003 Clermont-Ferrand, France; Clermont université, université d'Auvergne, EA7283, CIC501, BP 10448, 63000 Clermont-Ferrand, France.
Subjects: Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy ; Lymphoma, Mantle-Cell/Lymphoma, Mantle-Cell/Lymphoma, Mantle-Cell/*drug therapy ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*therapeutic use
-
Source:
Bulletin du cancer [Bull Cancer] 2016 Feb; Vol. 103 (2), pp. 127-37. Date of Electronic Publication: 2016 Jan 25.Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6917
Record details